Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 Through 11 Years of Age with Cystic Fibrosis Heterozygous for

Autor:	Marcus A, Mall, Rossa, Brugha, Silvia, Gartner, Julian, Legg, Alexander, Moeller, Pedro, Mondejar-Lopez, Dario, Prais, Tacjana, Pressler, Felix, Ratjen, Philippe, Reix, Paul D, Robinson, Hiran, Selvadurai, Florian, Stehling, Neil, Ahluwalia, Emilio, Arteaga-Solis, Bote G, Bruinsma, Mark, Jennings, Samuel M, Moskowitz, Sabrina, Noel, Simon, Tian, Tanya G, Weinstock, Pan, Wu, Claire E, Wainwright, Jane C, Davies
Rok vydání:	2022
Předmět:	Cystic Fibrosis Forced Expiratory Volume Mutation Humans Cystic Fibrosis Transmembrane Conductance Regulator Benzodioxoles Child Aminophenols Chloride Channel Agonists
Zdroj:	American journal of respiratory and critical care medicine. 206(11)
ISSN:	1535-4970
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=pmid________::49c2e1bfbfd3afb22d519c55106c179b https://pubmed.ncbi.nlm.nih.gov/35947636 Zobrazit plný text záznamu